Journal of Postgraduate Medicine
 Open access journal indexed with Index Medicus & ISI's SCI  
Users online: 3235  
Home | Subscribe | Feedback | Login 
About Latest Articles Back-Issues Article Submission Resources Sections Etcetera Contact
 
  NAVIGATE here  
  ::   Search
  ::   Ahead of print
  ::   Current Issue
  ::   Submit Article 
  ::   Apply as Referee 
  ::   JPGM WriteCon 
  ::   Current Symposium 

 


This article has been cited by
1How low can you go? Use of low- and standard-dose liposomal amphotericin B for treatment of invasive fungal infections
Zahra Kassamali,Larry H. Danziger,Robert C. Glowacki,David N. Schwartz
International Journal of Infectious Diseases.2013;17(8)e615
[DOI]
2How low can you go? Use of low- and standard-dose liposomal amphotericin B for treatment of invasive fungal infections
Martin Schmidt-Hieber
International Journal of Infectious Diseases.2015;17(8)211
[DOI]
3Burden of Serious Fungal Infections in Jordan
Jamal Wadi,David Denning
Journal of Fungi.2018;4(1)15
[DOI]
4Comparative Effectiveness of Induction Therapy for Human Immunodeficiency Virus-Associated Cryptococcal Meningitis: A Network Meta-Analysis
Jeffrey I. Campbell,Steve Kanters,John E. Bennett,Kristian Thorlund,Alexander C. Tsai,Edward J. Mills,Mark J. Siedner
Open Forum Infectious Diseases.2015;2(1)15
[DOI]
5Access to antifungal medicines in resource-poor countries – Authors' reply
Angela Loyse,Harry Thangaraj,Nelesh P Govender,Thomas Harrison,Tihana Bicanic
The Lancet Infectious Diseases.2014;14(5)371
[DOI]
6CNS infections in patients with hematological disorders (including allogeneic stem-cell transplantation)—Guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Medical Oncology (DGHO)
M. Schmidt-Hieber,G. Silling,E. Schalk,W. Heinz,J. Panse,O. Penack,M. Christopeit,D. Buchheidt,U. Meyding-Lamadé,S. Hähnel,H. H. Wolf,M. Ruhnke,S. Schwartz,G. Maschmeyer
Annals of Oncology.2016;27(7)1207
[DOI]
7New Insights into HIV/AIDS-Associated Cryptococcosis
Spinello Antinori
ISRN AIDS.2013;2013(7)1
[DOI]
8In vitroantifungal activity of Indian liposomal amphotericin B against clinical isolates of emerging species of yeast and moulds, and its comparison with amphotericin B deoxycholate, voriconazole, itraconazole and fluconazole
Shivaprakash M. Rudramurthy,Manu Jatana,Rachna Singh,Arunaloke Chakrabarti
Mycoses.2013;56(1)39
[DOI]
9Cryptococcal meningitis: improving access to essential antifungal medicines in resource-poor countries
Angela Loyse,Harry Thangaraj,Philippa Easterbrook,Nathan Ford,Monika Roy,Tom Chiller,Nelesh Govender,Thomas S Harrison,Tihana Bicanic
The Lancet Infectious Diseases.2013;13(7)629
[DOI]
10Access to antifungal medicines in resource-poor countries
Manoj P Jadhav,Nilima A Kshirsagar
The Lancet Infectious Diseases.2014;14(5)370
[DOI]
11Isolated cervical cryptococcal lymphadenitis without meningitis in an immunocompetent human immunodeficiency virus-negative child: a rare case report
Jeetendra Gurung,Wihiwot Valarie Lyngdoh,Annie B. Khyriem
JMM Case Reports.2014;1(3)370
[DOI]
12Early Fungicidal Activity as a Candidate Surrogate Endpoint for All-Cause Mortality in Cryptococcal Meningitis: A Systematic Review of the Evidence
Jairo M. Montezuma-Rusca,John H. Powers,Dean Follmann,Jing Wang,Brigit Sullivan,Peter R. Williamson,Eliseo A Eugenin
PLOS ONE.2016;11(8)e0159727
[DOI]
13Treatment for HIV-associated cryptococcal meningitis
Mark W Tenforde,Adrienne E Shapiro,Benjamin Rouse,Joseph N Jarvis,Tianjing Li,Ingrid Eshun-Wilson,Nathan Ford
Cochrane Database of Systematic Reviews.2018;11(8)e0159727
[DOI]
14Recent advances in development of amphotericin B formulations for the treatment of visceral leishmaniasis
Abeer H.A. Mohamed-Ahmed,Stephen Brocchini,Simon L. Croft
Current Opinion in Infectious Diseases.2012;25(6)695
[DOI]
Online since 12th February '04
© 2004 - Journal of Postgraduate Medicine
Official Publication of the Staff Society of the Seth GS Medical College and KEM Hospital, Mumbai, India
Published by Wolters Kluwer - Medknow